Skip to main content
Figure 4 | BMC Nephrology

Figure 4

From: HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

Figure 4

Survival, Dialysis Morbidity and Mortality Wave II Cohort (DMMS II), 1996 only, N = 3374, patients with Human Immunodeficiency Virus (HIV) associated nephropathy (HIVAN) who received combination retroviral therapy (COMBO) vs. all those who did not (NO COMBO), including those who were treated with single anti-retroviral agents, p = 0.77 by Log Rank Test.

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us